Latest Breaking News On - Chris stamm - Page 2 : comparemela.com

Takeda Pharmaceutical Company Limited: Takeda Enters Collaboration and Licensing Agreement with Zedira and Dr. Falk Pharma to Develop First-in-Class Celiac Disease Therapy

Collaboration Provides Takeda an Exclusive License to Develop and Commercialize ZED1227/TAK-227 in the United States and Other Countries Outside of Europe, Canada, Australia and China Agreement Adds

Takeda Pharmaceutical (TAK) and Arrowhead (ARWR) Announce Publication of Results from Phase 2 Study of Fazirsiran

Results from Phase 2 Study of Fazirsiran in Patients with Alpha-1 Antitrypsin Deficiency Published in New England Journal of Medicine

Takeda Pharmaceutical Company Limited: Takeda to Acquire GammaDelta Therapeutics to Accelerate Development of Allogeneic ?dT Cell Therapies Addressing Solid Tumors

Acquisition expands Takeda's immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging gamma-delta T cells for the potential treatment of solid tumors and hematological

Takeda to Commercialize Next-Generation Hunter Syndrome Therapy Through Collaboration with JCR Pharmaceuticals

Press release content from Business Wire. The AP news staff was not involved in its creation.